Medicine and Dentistry
Glycogen Storage Disease Type II
100%
Enzyme Replacement Therapy
39%
Magnetic Resonance Imaging
18%
Diseases
17%
Neuromuscular Disease
14%
Forced Vital Capacity
12%
Infusion
11%
Diaphragm
11%
Alglucosidase Alfa
11%
Neuromuscular Disorder
10%
Myopathy
10%
Weakness
10%
Spirometry
9%
COVID-19
8%
Patient-Reported Outcome
8%
Glucosidase
7%
Glucan 1,4 Alpha Glucosidase
6%
Lung Function
6%
Prospective Study
6%
Infection
6%
Clinician
6%
Systematic Review
5%
Standing
5%
Cardiovascular Disease
5%
Neurofilament
5%
Glycogen Metabolism
5%
Early Diagnosis
5%
Telemedicine
5%
Magnetic Resonance Imaging of Chest
5%
Diffusion Tensor Imaging
5%
Walking Ability
5%
Cohort Study
5%
Six Minute Walk Test
5%
NMR Spectroscopy
5%
Clinical Pathway
5%
Metabolic Disorder
5%
Lung
5%
Physical Activity
5%
Retrospective Cohort Study
5%
Storage Disease
5%
Bone Strength
5%
Awareness
5%
Pharmacology, Toxicology and Pharmaceutical Science
Glycogen Storage Disease Type 2
60%
Replacement Therapy
29%
Diseases
17%
Alglucosidase Alfa
12%
Cohort Study
9%
Myopathy
8%
Infection
5%
Prospective Study
5%
Glucan 1,4 Alpha Glucosidase
5%
Cardiovascular Disease
5%
Glycogen Storage Disease
5%
Biochemistry, Genetics and Molecular Biology
Enzyme
19%
Magnetic Resonance Imaging
11%
Cohort Study
8%
Acid Alpha-Glucosidase
8%
Lysosomal Storage Disease
6%
Fibroblast
6%
Case-Control Study
5%
Glycogen Metabolism
5%
Glycogen Branching Enzyme
5%
Genetic Approach
5%
Genetics
5%
Prevalence
5%
Patient Registry
5%
Neurofilament Light
5%
Genotyping
5%
Medical Decision Making
5%
Prospective Study
5%
Maltase
5%
Motion
5%